相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry
Nicholas Myles et al.
LEUKEMIA & LYMPHOMA (2021)
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Alexander C. Leeksma et al.
HAEMATOLOGICA (2021)
Drug rechanneling: A novel paradigm for cancer treatment
Itishree Kaushik et al.
SEMINARS IN CANCER BIOLOGY (2021)
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
Anuradha Kirtonia et al.
SEMINARS IN CANCER BIOLOGY (2021)
Repurposing of artemisinin-type drugs for the treatment of acute leukemia
Xiaohua Lu et al.
SEMINARS IN CANCER BIOLOGY (2021)
Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells
Gina L. Eagle et al.
SCIENTIFIC REPORTS (2021)
MARCKS affects cell motility and response to BTK inhibitors in CLL
Laura Beckmann et al.
BLOOD (2021)
Using What We Already Have: Uncovering New-Drug Repurposing Strategies in Existing Omics Data
Jill M. Pulley et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
A paradigm shift in medicine: A comprehensive review of network-based approaches
Federica Conte et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2020)
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Jennifer Edelmann et al.
HAEMATOLOGICA (2020)
PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia
Yu-Chen Enya Chen et al.
LEUKEMIA (2020)
BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia
Lindsay D. Smith et al.
LEUKEMIA (2020)
Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis
Yen-Chun Liu et al.
MODERN PATHOLOGY (2020)
Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia
Marc Sorigue et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2020)
Deep learning of pharmacogenomics resources: moving towards precision oncology
Yu-Chiao Chiu et al.
BRIEFINGS IN BIOINFORMATICS (2020)
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome
Christian Brieghel et al.
CLINICAL CANCER RESEARCH (2020)
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
Delphine Casabonne et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
New drugs are not enough-drug repositioning in oncology: An update
Romina Gabriela Armando et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Interaction between miRNAs and signaling cascades of Wnt pathway in chronic lymphocytic leukemia
Manojit Bhattacharya et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
The complex karyotype and chronic lymphocytic leukemia: prognostic value and diagnostic recommendations
Ludovic Jondreville et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools
Giovanna Nicora et al.
FRONTIERS IN ONCOLOGY (2020)
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Second cancer incidence in CLL patients receiving BTK inhibitors
David A. Bond et al.
LEUKEMIA (2020)
Cytoskeletal Crosstalk in Cell Migration
Shailaja Seetharaman et al.
TRENDS IN CELL BIOLOGY (2020)
Antihistamines are synergistic with Bruton's tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cells
Aaron Chanas-Larue et al.
LEUKEMIA RESEARCH (2020)
Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
Neus Gimenez et al.
SCIENTIFIC REPORTS (2020)
Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing
Ziaurrehman Tanoli et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Advancing precision medicine with personalized drug screening
Kirill Gorshkov et al.
DRUG DISCOVERY TODAY (2019)
An update on Drug Repurposing: Re-written saga of the drug's fate
Hema G. N. S. Sree et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Binding site comparisons for target-centered drug discovery
Janez Konc
EXPERT OPINION ON DRUG DISCOVERY (2019)
New roles for B cell receptor associated kinases: when the B cell is not the target
Phuong-Hien Nguyen et al.
LEUKEMIA (2019)
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
Brent M. Kuenzi et al.
SCIENTIFIC REPORTS (2019)
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
Suliman A. Alsagaby et al.
SAUDI MEDICAL JOURNAL (2019)
Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma
Fang-xiao Zhu et al.
MEDICAL SCIENCE MONITOR (2019)
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2019)
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia
Andrea Visentin et al.
BRITISH JOURNAL OF CANCER (2019)
Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes
Bahram Sharif-Askari et al.
SCIENTIFIC REPORTS (2019)
State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
Richard Lemal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic Leukemia A Case Series and Review of the Literature
Bianca M. Van Der Nest et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma
Chengwu Han et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2019)
Updates on the hematologic tumor microenvironment and its therapeutic targeting
Dorian Forte et al.
HAEMATOLOGICA (2019)
Chronic lymphocytic leukemia, skin and other second cancers
Stephen P. Mulligan et al.
LEUKEMIA & LYMPHOMA (2019)
Repurposing dasatinib for diffuse large B cell lymphoma
Claudio Scuoppo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
Vivek Kumar et al.
BLOOD CANCER JOURNAL (2019)
Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia
Adrian Mosquera Orgueira et al.
BLOOD CANCER JOURNAL (2019)
New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data
Adrian Mosquera Orgueira et al.
FRONTIERS IN GENETICS (2019)
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
Ilaria Del Giudice et al.
FRONTIERS IN ONCOLOGY (2019)
Drug Repurposing in the Development of Anticancer Agents
Sureyya Olgen et al.
CURRENT MEDICINAL CHEMISTRY (2019)
The evolving treatment landscape of chronic lymphocytic leukemia
Luana Schiattone et al.
CURRENT OPINION IN ONCOLOGY (2019)
An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States
Taisen Hao et al.
SCIENTIFIC REPORTS (2019)
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas et al.
BLOOD (2019)
B-cell lymphomas present immunoglobulin neoantigens
Michael S. Khodadoust et al.
BLOOD (2019)
Using human experience to identify drug repurposing opportunities: theory and practice
D. Cavalla
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis
Lauren A. Thurgood et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Prognostic and clinicopathological significance of PD-1/PD-Li expression in the tumor microenvironment and neoplastic cells for lymphoma
Mixue Xie et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay
Katerina Katsaraki et al.
LEUKEMIA RESEARCH (2019)
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia
Steven M. Bair et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Use of big data in drug development for precision medicine: an update
Tongqi Qian et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2019)
Advances in Epigenetics and Epigenomics in Chronic Lymphocytic Leukemia
Charalampos Xanthopoulos et al.
CURRENT GENETIC MEDICINE REPORTS (2019)
Identifying Drug Repurposing Opportunities in Oncology
Stefania Orecchioni et al.
CANCER JOURNAL (2019)
Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
Mesude Falay et al.
CLINICAL LABORATORY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy
V. K. Patel et al.
LEUKEMIA (2018)
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
K. Karube et al.
LEUKEMIA (2018)
Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia
Rupert L. Mayer et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
Gian Matteo Rigolin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Proteomic Profile Of Lymphoid Leukemia
Amer Abdulrahman Almaiman
JCPSP-Journal of the College of Physicians and Surgeons Pakistan (2018)
BCL-2 as therapeutic target for hematological malignancies
Guilherme Fleury Perini et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
J. Malcikova et al.
LEUKEMIA (2018)
Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation
Harvey E. Johnston et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
Subir Roy Chowdhury et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact
Larry Mansouri et al.
SEMINARS IN CANCER BIOLOGY (2018)
Network-based approach to prediction and population-based validation of in silico drug repurposing
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2018)
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
Elena Pineiro-Yanez et al.
GENOME MEDICINE (2018)
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
Emanuela Rosati et al.
FRONTIERS IN ONCOLOGY (2018)
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
Gabriel Bretones et al.
BLOOD (2018)
Review of Drug Repositioning Approaches and Resources
Hanqing Xue et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Maurizio Mangolini et al.
NATURE COMMUNICATIONS (2018)
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
Alessandro Lagana et al.
JCO PRECISION ONCOLOGY (2018)
A review of network-based approaches to drug repositioning
Maryam Lotfi Shahreza et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3Kδ in Mature B-cell Malignancies
Jeffrey D. Cooney et al.
CLINICAL CANCER RESEARCH (2018)
Functional proteomic insights in B-cell chronic lymphocytic leukemia
Paula Diez et al.
EXPERT REVIEW OF PROTEOMICS (2017)
Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors
Vivek Kumar Singh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2017)
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
Martijn H. A. van Attekum et al.
HAEMATOLOGICA (2017)
Deciphering lymphoma pathogenesis via state-of-the-art mass spectrometry-based quantitative proteomics
Konstantina Psatha et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T3151 mutant and wild-type BCR-ABL1: A virtual screening and molecular dynamics study
Farzin Sohraby et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)
From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia
Lauren A. Thurgood et al.
JOURNAL OF PROTEOMICS (2017)
Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures
Harvey E. Johnston et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells
Paula Diez et al.
ONCOTARGET (2017)
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
Martijn H. A. van Attekum et al.
HAEMATOLOGICA (2017)
Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas
Pavlina Janovska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Therapeutic drug repositioning using personalized proteomics of liquid biopsies
Gabriel Velez et al.
JCI INSIGHT (2017)
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2017)
S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progression
Daniel Prieto et al.
BLOOD (2017)
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Franziska Haderk et al.
SCIENCE IMMUNOLOGY (2017)
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
Viktoras Frismantas et al.
BLOOD (2017)
Protein profiles distinguish stable and progressive chronic lymphocytic leukemia
Pauline Y. Huang et al.
LEUKEMIA & LYMPHOMA (2016)
Chronic lymphocytic leukemia (CLL)Then and now
Kanti R. Rai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Targeted therapies for CLL: Practical issues with the changing treatment paradigm
Nitin Jain et al.
BLOOD REVIEWS (2016)
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins
Federica Frezzato et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia
Paula Diez et al.
PROTEOMICS (2016)
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Ciara L. Freeman et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2016)
Pros and Cons of the Proteomics
Ashish Gupta et al.
Biomedical Journal (2016)
Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib
Jeff Sharman et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
Repurposing medicinal compounds for blood cancer treatment
Bronagh McCabe et al.
ANNALS OF HEMATOLOGY (2015)
Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling
Regina Jitschin et al.
BLOOD (2015)
Drug repositioning and repurposing: terminology and definitions in literature
Joris Langedijk et al.
DRUG DISCOVERY TODAY (2015)
Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia
Gina L. Eagle et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
A. Eriksson et al.
BLOOD CANCER JOURNAL (2015)
RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia
Austin Y. Shull et al.
ONCOTARGET (2015)
The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia
Kimberley L. Kaufman et al.
ONCOTARGET (2015)
Proteomic profiling identifies specific histone species associated with leukemic and cancer cells
Rajbir Singh et al.
CLINICAL PROTEOMICS (2015)
The biology behind PI3K inhibition in chronic lymphocytic leukaemia
Valentin Ortiz-Maldonado et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
Quantitative Proteomics to Characterize Specific Histone H2A Proteolysis in Chronic Lymphocytic Leukemia and the Myeloid THP-1 Cell Line
Pieter Glibert et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Proteomics-Based Strategies To Identify Proteins Relevant to Chronic Lymphocytic Leukemia
Suliman A. Asagaby et al.
JOURNAL OF PROTEOME RESEARCH (2014)
The Pathogenesis of Chronic Lymphocytic Leukemia
Suping Zhang et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
Hsp90 Inhibitor SNX-7081 Dysregulates Proteins Involved with DNA Repair and Replication and the Cell Cycle in Human Chronic Lymphocytic Leukemia (CLL) Cells
Yiping Che et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen
Elena Kashuba et al.
JOURNAL OF PROTEOMICS (2013)
Identification of endoplasmic reticulum stress-inducing agents by antagonizing autophagy: a new potential strategy for identification of anti-cancer therapeutics in B-cell malignancies
Emilia Mahoney et al.
LEUKEMIA & LYMPHOMA (2013)
Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs
Min Shen et al.
PLOS ONE (2013)
Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays
Christoph Schroeder et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia
Aurore Perrot et al.
BLOOD (2011)
Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells
U. Kruse et al.
LEUKEMIA (2011)
FLUDARABINE NUCLEOSIDE MODULATES NUCLEAR SURVIVAL AND DEATH PROTEINS IN RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
Silke Henrich et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia
Karen S. Rees-Unwin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis
Morgan O'Hayre et al.
PLOS ONE (2010)
Proteomic Analysis of Malignant B-Cell Derived Microparticles Reveals CD148 as a Potentially Useful Antigenic Biomarker for Mantle Cell Lymphoma Diagnosis
Laurent Miguet et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia
Xiaodan Su et al.
PROTEOMICS (2009)
A concentration-dependent analysis method for high density protein microarrays
Ovidiu Marina et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Differentially expressed nuclear proteins in human CCRF-CEM, HL-60, MECA and Raji cells correlate with cellular properties
Silke Henrich et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Differentially expressed cytosolic proteins in human leukemia and lymphoma cell lines correlate with lineages and functions
Swetlana Gez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2007)
Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS
Laurent Miguet et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgVH subgroups using acid-cleavable isotope-coded affinity tag reagents
DR Barnidge et al.
JOURNAL OF PROTEOME RESEARCH (2005)
HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses
C Scielzo et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig VH genes
DAE Cochran et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B
RS Boyd et al.
LEUKEMIA (2003)
分享论文
